Understanding radioimmunotherapy

Alpha radioimmunotherapy (alpha RIT) is a powerful anticancer therapy that targets cancerous cells without affecting the body’s healthy normal cells.
The potential of alpha radioimmunotherapy
Alpha RIT works by binding an isotope, such as 212Pb, to a monoclonal antibody.
Using the body’s own antigens, this treatment targets only cancer cells and destroys them.
It shows great promise for the treatment of numerous types of cancers, such as pancreatic, ovarian, melanoma, and others that do not respond efficiently to existing treatments.
How radioimmunotherapy works

Solar simplified
Alpha Ventus wind turbines in the North Sea
Offshore turbine - 3D presentation
MISTRAL 20-600 kVA Fuel cell Backup power system
Gilles, Civil Engineering Referent
Jean-Christophe, Mechanical Calculation Engineer
Emmanuelle, Solar R&D Program Manager
"AREVA at a glance" brochure
Solutions for nuclear and renewable power generation (english only)
Report on diversity 2010
